OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Care is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Overestimation of driving pressure by the analysis of the conductive pressure during venous-arterial ECMO: Airway Closure or Intrinsic PEEP?	486
Hidden Harlequin syndrome in neonatal and pediatric VA-ECMO	425
What every intensivist needs to know about mpox	396
Novel protocol combining physical and nutrition therapies, Intensive Goal-directed REhabilitation with Electrical muscle stimulation and Nutrition (IGREEN) care bundle	328
Sodium azide (NaN3) intoxication, “the man who lived”: potential effective antidote and treatment strategy	224
Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score	199
AVDS should not dethrone ARDS	194
Volatile anaesthetics for ICU sedation: beyond hypnosis?	157
Flow Index accurately identifies breaths with low or high inspiratory effort during pressure support ventilation	134
Video versus direct laryngoscopy in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials	124
Effectiveness of targeted post-acute interventions and follow-up services for sepsis survivors: a systematic review	122
Evaluation of the impact of artificial intelligence-assisted image interpretation on the diagnostic performance of clinicians in identifying endotracheal tube position on plain chest X-ray: a multi-ca	120
Feasibility of bedside portable MRI in neonates and children during ECLS	112
The protective effect of apolipoprotein H in paediatric sepsis	110
Termination-of-resuscitation rule in the emergency department for patients with refractory out-of-hospital cardiac arrest: a nationwide, population-based observational study	107
A randomized controlled trial of catheters with different tips and lengths for patients requiring continuous renal replacement therapy in intensive care unit	104
The association between the presence and burden of periodic discharges and outcome in septic patients: an observational prospective study	103
Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial	102
Bronchus-blocked ultrasound-guided percutaneous transthoracic needle biopsy (BUS-PTNB) for intubated patients with severe lung diseases	99
Prevalence of long-term decision regret and associated risk factors in a large cohort of ICU surrogate decision makers	99
What criteria for neuropronostication: consciousness or ability? The neuro-intensivist’s dilemma	97
Care pathways of sepsis survivors: sequelae, mortality and use of healthcare services in France, 2015–2018	95
A genome-wide association study of survival in patients with sepsis	94
Real-time monitoring of air pathogens in the ICU with biosensors and robots	93
Machine learning models compared with current clinical indices to predict the outcome of high flow nasal cannula therapy in acute hypoxemic respiratory failure	91

Pyroptosis in sepsis-associated acute kidney injury: mechanisms and therapeutic perspectives	88
Advanced respiratory mechanics assessment in mechanically ventilated obese and non-obese patients with or without acute respiratory distress syndrome	85
One-year patient outcomes based on lung morphology in acute respiratory distress syndrome: secondary analysis of LIVE trial	85
Host Response Biomarkers for Sepsis in the Emergency Room	85
Family concerns in organ donor conversations: a qualitative embedded multiple-case study	83
How symptoms of prolonged grief disorder, posttraumatic stress disorder, and depression relate to each other for grieving ICU families during the first two years of bereavement	80
Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trial	80
Restrictive fluid management with early de-escalation versus usual care in critically ill patients (reduce trial): a feasibility randomized controlled trial	79
Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1	78
Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 study	77
Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit	73
Blood trauma in veno-venous extracorporeal membrane oxygenation: low pump pressures and low circuit resistance matter	72
Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a secondary analysis of the Prague OHCA trial	71
Early intubation and patient-centered outcomes in septic shock: a secondary analysis of a prospective multicenter study	69
COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation	68
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis	68
The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation	67
qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in emergency department: a bit sweet and a bit sour randomized controlled trial	66
Advanced Life Support Update	66
Scoring system: use and not use from the future to present	65
Red blood cell transfusion in brain injury: Is it solely a matter of hemoglobin threshold?	65
How I manage differential gas exchange in peripheral venoarterial extracorporeal membrane oxygenation	64
Response to the Letter by Spurling and Colleagues	64
Longitudinal assessment of immunoglobulin response and disease progression in critically ill patients with community acquired pneumonia	63
Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF)	63
The management of heart failure cardiogenic shock: an international RAND appropriateness panel	63
The INTOXICATE study: methodology and preliminary results of a prospective observational study	63
Network of job demands-resources and depressive symptoms in critical care nurses: a nationwide cross-sectional study	62
Haloperidol is not the “one drug fits all” solution in the treatment of delirium	62
A pleural drainage tube misplaced into the right atrium	61
Time course of electrical activity of the diaphragm (EAdi) in the peri extubation period and its role as predictor of extubation failure in difficult to wean patients	60
Demographics and outcome of Legionella pneumonia in the intensive care unit: a retrospective multicenter cohort study	60
Is comorbidity alone responsible for changes in health-related quality of life among critical care survivors? A purpose-specific review	59
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis	58
Gut-derived immune cells and the gut-lung axis in ARDS	58
REmoval of cytokines during CArdiac surgery (RECCAS): a randomised controlled trial	58
A novel capnogram analysis to guide ventilation during cardiopulmonary resuscitation: clinical and experimental observations	58
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized cont	58
Quantitative analysis of apparent diffusion coefficients to predict neurological prognosis in cardiac arrest survivors: an observational derivation and internal–external validation study	58
Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial	58